Science Explorer Back to mapMap
Discussion
Company · Seongnam-si · South Korea

Biocera (South Korea)

Research works
11
▼ 61% vs 2018-21
Citations
188
17.7 per fractional work
Top-10% rate
3.6%
all institutions 10.0%
Open access
48%
world 40%
International
40%
world 18%

Not ranked overall: Biocera (South Korea) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Biocera (South Korea) work in?

In all years, 57% of research at Biocera (South Korea) is in Physical Sciences, 22% in Health Sciences. Its largest fields are Materials Science (25%), Medicine (18%), Engineering (13%).

Physical Sciences: 6 fractional works · 57.4% of its workMaterials Science: 3 fractional works · 25.2% of its workBiomaterials: 2 fractional works · 14.5% of its workMaterials Chemistry: 1 fractional works · 7.1% of its workPolymers and Plastics: 0 fractional works · 2.3% of its workSurfaces, Coatings and Films: 0 fractional works · 1.0% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.4% of its workEngineering: 1 fractional works · 13.2% of its workBiomedical Engineering: 1 fractional works · 9.5% of its workElectrical and Electronic Engineering: 0 fractional works · 3.1% of its workMechanical Engineering: 0 fractional works · 0.6% of its workChemistry: 1 fractional works · 8.7% of its workOrganic Chemistry: 1 fractional works · 8.7% of its workComputer Science: 0 fractional works · 4.7% of its workComputer Networks and Communications: 0 fractional works · 3.1% of its workInformation Systems: 0 fractional works · 1.6% of its workEnvironmental Science: 0 fractional works · 4.7% of its workWater Science and Technology: 0 fractional works · 3.1% of its workPollution: 0 fractional works · 1.0% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.6% of its workChemical Engineering: 0 fractional works · 0.6% of its workBioengineering: 0 fractional works · 0.6% of its workEnergy: 0 fractional works · 0.3% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.3% of its workHealth Sciences: 2 fractional works · 22.5% of its workMedicine: 2 fractional works · 18.3% of its workNeurology: 0 fractional works · 3.7% of its workPathology and Forensic Medicine: 0 fractional works · 2.4% of its workSurgery: 0 fractional works · 2.4% of its workPhysiology: 0 fractional works · 2.2% of its workBiochemistry: 0 fractional works · 1.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.4% of its workOncology: 0 fractional works · 0.8% of its workEpidemiology: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workDermatology: 0 fractional works · 0.6% of its workUrology: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.3% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.2% of its workDentistry: 0 fractional works · 4.1% of its workOrthodontics: 0 fractional works · 2.3% of its workOral Surgery: 0 fractional works · 1.9% of its workLife Sciences: 2 fractional works · 20.1% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 9.9% of its workMolecular Biology: 1 fractional works · 8.2% of its workBiotechnology: 0 fractional works · 1.0% of its workCell Biology: 0 fractional works · 0.7% of its workAgricultural and Biological Sciences: 1 fractional works · 6.8% of its workPlant Science: 0 fractional works · 4.1% of its workFood Science: 0 fractional works · 1.6% of its workSoil Science: 0 fractional works · 1.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.8% of its workPharmaceutical Science: 0 fractional works · 1.8% of its workImmunology and Microbiology: 0 fractional works · 0.9% of its workImmunology: 0 fractional works · 0.9% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.8% of its workALL ITS WORKBiocera (SouthKorea)11fractional works, all years
Life Sciences20%Physical Sciences57%Health Sciences22%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 14 fields, with their numbers
    1. Materials Science325.2%
    2. Engineering113.2%
    3. Chemistry18.7%
    4. Computer Science04.7%
    5. Environmental Science04.7%
    6. Chemical Engineering00.6%
    7. Energy00.3%
    1. Medicine218.3%
    2. Dentistry04.1%
    1. Biochemistry, Genetics and Molecular Biology19.9%
    2. Agricultural and Biological Sciences16.8%
    3. Pharmacology, Toxicology and Pharmaceutics01.8%
    4. Immunology and Microbiology00.9%
    5. Neuroscience00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.89× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.98× its world share, 0 worksBiochemistry, Geneti…Chemistry: 4.29× its world share, 0 worksChemistryComputer Science: 2.60× its world share, 0 worksComputer ScienceEngineering: 0.90× its world share, 0 worksEngineeringMaterials Science: 5.14× its world share, 0 worksMaterials ScienceMedicine: 1.15× its world share, 0 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Materials Science, 5.1×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Materials Science5.14×0 works
  2. Chemistry4.29×0 works
  3. Computer Science2.60×0 works
  4. Biochemistry, Genetics and Molecular Biology1.98×0 works
  5. Agricultural and Biological Sciences1.89×0 works
  6. Medicine1.15×0 works
  7. Engineering0.90×0 works

What are the most cited papers from Biocera (South Korea)?

The most cited paper from Biocera (South Korea) is "Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis" (Nazila Kamaly, Gabrielle Fredman, Jhalique Jane R. Fojas et al., 2016), with 222 citations. Next come "Targeted Nanoparticles for Colorectal Cancer" (169) and "Carbon nanotube doped pericardial matrix derived electroconductive biohybrid hydrogel for cardiac tissue engineering" (116).

Most cited papers
#PaperReleasedCitations
1 Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis Nazila Kamaly, Gabrielle Fredman, Jhalique Jane R. Fojas et al. · ACS Nano Open access 21 Apr 2016 222
2 Targeted Nanoparticles for Colorectal Cancer Bruno A. Cisterna, Nazila Kamaly, Won Il Choi et al. · Nanomedicine Open access 16 Aug 2016 169
3 Carbon nanotube doped pericardial matrix derived electroconductive biohybrid hydrogel for cardiac tissue engineering Kaveh Roshanbinfar, Zahra Mohammadi, Abdorreza Sheikh-Mehdi Mesgar et al. · Biomaterials Science 2019 116
4 An injectable and physical levan-based hydrogel as a dermal filler for soft tissue augmentation Won Il Choi, Young-Min Hwang, Abhishek Sahu et al. · Biomaterials Science 2018 83
5 Reactive oxygen species (ROS)-responsive ferrocene-polymer-based nanoparticles for controlled release of drugs Yoonhee Na, Jin Sil Lee, Jiseob Woo et al. · Journal of Materials Chemistry B 2020 77
All 38 most cited papers, with filters and sorting

Which research topics does Biocera (South Korea) publish most on?

By volume in 2022-now: Nanocomposite Films for Food Packaging, Nanomaterials for catalytic reactions, Software-Defined Networks and 5G and Intracranial Aneurysms: Treatment and Complications.

  1. 1 Nanocomposite Films for Food Packaging Biomaterials 0 works
  2. 2 Nanomaterials for catalytic reactions Organic Chemistry 0 works
  3. 3 Software-Defined Networks and 5G Computer Networks and Communications 0 works
  4. 4 Intracranial Aneurysms: Treatment and Complications Neurology 0 works
  5. 5 Trigeminal Neuralgia and Treatments Pathology and Forensic Medicine 0 works
  6. 6 Advanced Sensor and Energy Harvesting Materials Biomedical Engineering 0 works
  7. 7 IoT and Edge/Fog Computing Computer Networks and Communications 0 works
  8. 8 Electrochemical sensors and biosensors Electrical and Electronic Engineering 0 works
  9. 9 Big Data and Digital Economy Information Systems 0 works
  10. 10 Conducting polymers and applications Polymers and Plastics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.7%not open52.3%

World: 40% of research is openly available.

with international co-authors39.5%domestic only60.5%

World: 18% is written across borders.

How has Biocera (South Korea)'s research output changed?

Output in 2022-2025 was 61% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Biocera (South Korea) as a percentage of every work published that year, 0.0000025% in 2024.

still counting0.000020%0.000040%0.000060%Biocera (South Korea)0.0000085% in 20252020

Fractional works of Biocera (South Korea) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Biocera (South Korea). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.